EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)

• Record Nr.: UNINA9910711623503321
• Pubbl/distr/stampa: Washington : , : U.S. Government Publishing Office, , 2018
• Descrizione fisica: 1 online resource (iii, 43 pages) : illustrations
• Collana: S. hrg. ; ; 114-805
• Soggetti: Prescription pricing - United States; Drugs - Law and legislation - United States; Pharmaceutical industry - United States; Competition - United States; Drug delivery devices - Prices - United States; Legislative hearings.
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Nota di bibliografia: Includes bibliographical references.